Microba Life Sciences Limited
MAP
Rank in Stocks
#26953
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Share Price
$0.02353446
Last synced: 2026-11-09
Market Cap
$17.48M
Change (1 day)
-8.27%
Change (1 year)
-54.92%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Microba Life Sciences Limited (MAP)
Category
Healthcare
EPS for Microba Life Sciences Limited (MAP)
EPS as of June 2026 TTM: $-0.02
According to Microba Life Sciences Limited's latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for Microba Life Sciences Limited from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | 21.50% |
| 2025 | $-0.02 | -32.41% |
| 2024 | $-0.03 | 27.56% |
| 2023 | $-0.03 | -6.62% |
| 2022 | $-0.03 | 40.21% |
| 2021 | $-0.02 | 22.78% |
| 2020 | $-0.02 | 38.60% |
| 2019 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -78,248.15% |
US
|
|
| $6.12 | -25,285.19% |
US
|
|
| $1.38 | -5,767.08% |
CN
|
|
| $14.83 | -61,128.81% |
US
|
|
| $5.09 | -21,046.50% |
US
|
Questions about Microba Life Sciences Limited's earnings per share (EPS)
What is Microba Life Sciences Limited's earnings per share (EPS)?
Microba Life Sciences Limited's earnings per share (EPS) over the last twelve months is $-0.02, as of Jun 2026.
What was Microba Life Sciences Limited's earnings per share (EPS) in 2025?
In 2025, Microba Life Sciences Limited's earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has Microba Life Sciences Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Microba Life Sciences Limited's earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2024 ($-0.03).
How does Microba Life Sciences Limited's earnings per share (EPS) compare with similar companies?
Microba Life Sciences Limited's earnings per share (EPS) ($-0.02) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.